Monday, 19 February 2024

Covid 'Booster' Shots Cause Heart Failure in Young Adults, Top Study Confirms




A new peer-reviewed study has confirmed that Covid mRNA “booster” shots are causing heart failure to soar in young adults and teenagers..

The study, published in the world-renowned European Heart Journal on February 15, found that a third dose of the Pfizer or Moderna injections is directly linked to the “increased incidence rate of myocarditis.”

Myocarditis is inflammation of the heart muscle (myocardium), according to the Mayo Clinic.

The inflammation can reduce the heart’s ability to pump blood, leading to blood clots, strokes, cardiac arrest, a potentially death.

Myocarditis is a known side effect  of the Covid mRNA vaccines but most people are unaware that they have it, making it a potential ticking timebomb for sufferers.

The vaccine-induced heart injury is believed to be the leading cause  of the recent spike in sudden and unexpected deaths

The researchers said the spikes in myocarditis are more apparent in young adults and adolescents, particularly males.

As Slay News has reported, cases of myocarditis have been skyrocketing around the world since the public rollout of the Covid shots in early 2021.

According to the new study, using data from several Nordic nations, researchers evaluated the risk of myocarditis among 12- to 39-year-olds after receiving COVID-19 mRNA booster vaccination.

The study analyzed data from 8.9 million young adults from four nations: Denmark, Finland, Norway, and Sweden.

In total, 1,533 cases of myocarditis were identified, which the researchers noted were all caused by the mRNA boosters.

The study concluded that the “booster dose is associated with increased myocarditis risk in adolescents and young adults.”

Among males, a third dose of the Pfizer or Moderna vaccine was associated with an “increased incidence rate of myocarditis” within 28 days of inoculation compared to a longer period after the second dose.

The study noted that the association of myocarditis with COVID-19 mRNA vaccines has appeared “strongest in male adolescents and younger males and after the second dose.”

The study was authored by 12 experts from the Norwegian Institute of Public Health, Swedish Medical Products Agency, Statens Serum Institut, and the Finnish Institute for Health and Welfare.

According to a separate study published in late January, cases of myocarditis among vaccinated individuals in the United States spiked within the first year of the COVID-19 vaccination campaign.

The U.S. study looked at data from the U.S. Centers for Disease Control and Prevention’s (CDC) Vaccine Adverse Event Reporting System (VAERS).

“We found the number of myocarditis reports in VAERS after COVID-19 vaccination in 2021 was 223 times higher than the average of all vaccines combined for the past 30 years,” the U.S. study said.

“This represented a [2,500 percent] increase in the absolute number of reports in the first year of the campaign when comparing historical values prior to 2021.”

Roughly 50 percent of myocarditis cases occurred among youths and 69 percent of affected individuals were males.

Out of a total of 3,078 COVID-19 vaccine-induced myocarditis cases as of August 2023, 76 percent resulted in emergency care and hospitalization, and 3 percent died.

New studies are being published looking at reducing myocarditis risk when vaccinating adolescents against COVID-19,

The mounting studies confirm that the risk of heart failure massively escalates each time a person receives an mRNA injection.

A February 14 study in the journal Vaccines found that extending the interval between the first and the second dose of COVID-19 mRNA vaccines leads to a 66 percent “lower risk of incident carditis among adolescents.”

Carditis is the general term for inflammation of the heart.

The study referred to adolescents as a “vulnerable population” while pointing out that “previous studies indicate an increased carditis risk among adolescents following the two-dose messenger RNA COVID-19 vaccine.”

There have been suggestions that COVID-19 infections cause more myocarditis cases than the vaccines.

However, multiple experts and major studies have disputed these claims.

Among those disputing the claim that COVID-19 infections cause myocarditis is world-renowned cardiologist Dr. Peter McCullough.

In a post on his website, he described this argument as “a twisted rationale for giving out COVID-19 vaccines, and in a perverted manner, creating more myocarditis in the population.

“If SARS-CoV-2 infection caused myocarditis or inflammation of heart muscle tissue, then it would be seen on autopsy in fatal cases of COVID-19.”

Dr. McCullough cited an October 2022 study involving an autopsy of the hearts of COVID-19-infected individuals.

The analysis “concluded the virus does not infect the heart,” he said.

The cardiologist called claims of the COVID-19 virus infecting the heart and causing myocarditis “false claims made from automated hospital data and not adjudicated, autopsy-proven cases.”

“The COVID-19 vaccines install mRNA in the heart and the Spike protein directly damages and incites inflammation into the heart muscle causing the pathophysiology we see every day in cardiology practice,” he wrote.

Researchers from a Jan. 24 U.S. study who looked into the initial phase 3 trials of Pfizer and Moderna COVID-19 mRNA vaccines found that their estimated harms “greatly outweigh the rewards.”

After determining that the injections do more harm than good, they called on world governments to impose a “global” ban on the COVID-19 vaccines “given the well-documented [serious adverse events] and unacceptable harm-to-reward ratio.”

The authors also recommended an “immediate removal” of COVID-19 vaccines from the childhood immunization schedule.

They pointed out that children are at very low risk of infection.


No comments:

Post a Comment